Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

Last Close
234.85
Aug 19 • 3:59 PM ET Dollar change0.00 Percentage change(0.00%)
Index
S&P 500
Market Cap
54.62B
Enterprise Value
59.87B
Income
1.71B
Sales
254.25B
Book/sh
-12.37
Cash/sh
20.88
Employees
63900
IPO
Aug 04, 1983
P/E
32.45
Forward P/E
16.67
PEG
1.44
P/S
0.21
P/B
-
P/C
11.25
P/FCF
12.07
EV/EBITDA
14.13
EV/Sales
0.24
Quick Ratio
0.49
Current Ratio
0.88
Debt/Eq
-
LT Debt/Eq
-
Option/Short
Yes / Yes
EPS (ttm)
7.24
EPS next Y
14.09
EPS next Q
2.94
EPS this Y
11.39%
EPS next Y
12.34%
EPS next 5Y
11.59%
EPS past 3/5Y
79.07% 28.33%
Sales past 3/5Y
7.44% 9.37%
EPS Y/Y TTM
12.28%
Sales Y/Y TTM
14.23%
EPS Q/Q
70.07%
Sales Q/Q
5.84%
Insider Own
0.43%
Insider Trans
-0.27%
Inst Own
90.34%
Inst Trans
-2.41%
ROA
3.10%
ROE
-
ROIC
34.40%
Gross Margin
3.70%
Oper. Margin
1.29%
Profit Margin
0.67%
SMA20
0.62%
SMA50
1.62%
SMA200
9.98%
Trades
Shs Outstand
233.00M
Shs Float
231.58M
52W High
258.30 -9.08%
52W Low
145.87 61.00%
Volatility
2.40% 2.69%
ATR (14)
6.29
RSI (14)
53.43
Beta
0.52
Rel Volume
0.00
Avg Volume
2.24M
Volume
0
Perf Week
0.29%
Perf Month
3.42%
Perf Quarter
17.21%
Perf Half Y
4.38%
Perf YTD
14.28%
Perf Year
57.60%
Perf 3Y
173.56%
Perf 5Y
357.62%
Perf 10Y
187.38%
Prev Close
234.85
Price
234.85
Change %
0.00%
Date Action Analyst Rating Change Price Target Change
Aug-19-26Initiated RBC Capital Mkts Outperform $276
Apr-28-26Initiated William Blair Outperform
Jan-09-26Upgrade Citigroup Neutral → Buy
Dec-09-25Initiated Barclays Overweight $243
Jun-03-25Upgrade Wells Fargo Equal Weight → Overweight $179
Feb-05-25Upgrade Jefferies Hold → Buy $140 → $150
Jan-08-25Upgrade TD Cowen Hold → Buy $130 → $144
Jan-07-25Upgrade Evercore ISI In-line → Outperform $140
Jan-06-25Upgrade BofA Securities Neutral → Buy $132 → $145
Dec-13-24Upgrade Wells Fargo Underweight → Equal Weight $101 → $127
Aug-19-26 09:38AM
Aug-18-26 07:13AM
Aug-13-26 06:10PM
Aug-11-26 05:03PM
01:25PM
10:13AM Loading…
10:13AM
10:07AM
09:02AM
08:54AM
08:00AM
07:38AM
07:25AM
07:03AM
06:45AM
06:40AM
05:10AM Loading…
05:10AM
04:06AM
Jul-27-26 09:54AM
Jul-21-26 12:15PM
04:46AM
Jul-20-26 04:45PM
Jul-09-26 09:24AM
06:45AM
Jul-08-26 02:24PM
May-05-26 04:40PM
Apr-30-26 04:55PM
08:07AM
07:41AM
06:56AM
06:45AM
12:30AM Loading…
12:30AM
Apr-28-26 11:45AM
10:19AM
Apr-20-26 12:12PM
Apr-14-26 07:00AM
Apr-07-26 08:20PM
Apr-01-26 07:00AM
Mar-24-26 06:45AM
Mar-23-26 06:45AM
Mar-13-26 04:41PM
09:55AM
Mar-10-26 01:11PM
10:55AM
Mar-09-26 11:53AM
09:40AM
Mar-06-26 07:12PM
11:49AM
11:45AM
11:44AM
Mar-05-26 12:46PM
10:56AM
09:30AM
07:43AM
Mar-04-26 11:35AM
08:30AM
Mar-03-26 10:38PM
07:02PM
09:40AM
09:15AM
Mar-02-26 12:59PM
09:40AM
09:36AM
07:41AM
07:41AM
Feb-28-26 01:28PM
Feb-27-26 12:45PM
12:38PM
12:37PM
07:42AM
Feb-26-26 08:04PM
07:12PM
11:46AM
11:22AM
Feb-25-26 01:55PM
01:55PM
12:51PM
12:49PM
07:50AM
07:26AM
Feb-24-26 12:40PM
12:15PM
08:46AM
07:45AM
07:00AM
Feb-23-26 03:35PM
12:42PM
10:11AM
09:32AM
Feb-20-26 06:11PM
12:22PM
11:48AM
09:11AM
04:13AM
Feb-19-26 04:44PM
12:08PM
09:40AM
08:33AM
08:16AM
08:09AM
Feb-18-26 08:55AM
Cardinal Health, Inc. is a healthcare services and products company, which engages in the provision of customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, and physician offices. It also provides medical products and pharmaceuticals and cost-effective solutions that enhance supply chain efficiency. The firm operates through the Pharmaceutical and Specialty Solutions Segment and Global Medical Products and Distribution Segment. The Pharmaceutical and Specialty Solutions Segment distributes branded and generic pharmaceutical, specialty pharmaceutical, and over-the-counter healthcare and consumer products in the United States. The Global Medical Products and Distribution Segment manufactures, sources, and distributes Cardinal Health brand medical, surgical, and laboratory products, which are sold in the United States, Canada, Europe, Asia, and other markets. The company was founded by Robert D. Walter in 1979 and is headquartered in Dublin, OH.
CEO & DirectorMr. Jason M. Hollar
Chief Executive Officer of Pharmaceutical & Specialty Solutions SegmentMs. Deborah L. Weitzman
Senior VP & Chief Accounting OfficerMs. Mary C. Scherer
Chief Human Resources OfficerMs. Valerie Christine Pitteroff
President of Biopharma Solutions & Strategic SourcingMr. Craig Cowman
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Mary SchererOfficerAug 19 '26Proposed Sale237.392,302546,462Aug 19 04:27 PM
Aaron AltOfficerAug 18 '26Proposed Sale236.3442,0009,926,183Aug 18 04:46 PM
Michelle GreeneOfficerAug 18 '26Proposed Sale235.7211,6502,746,148Aug 18 04:46 PM
Deborah WeitzmanOfficerAug 18 '26Proposed Sale235.457,3541,731,534Aug 18 04:45 PM
Jessica MayerOfficerAug 18 '26Proposed Sale236.1929,4366,952,441Aug 18 04:45 PM
Stephen MasonOfficerAug 18 '26Proposed Sale236.4035,0008,274,153Aug 18 04:44 PM
Jason HollarOfficerAug 18 '26Proposed Sale235.74124,52929,356,358Aug 18 04:44 PM
Gregory KennyFormer DirectorJun 08 '26Proposed Sale203.8443,5428,875,761Jun 08 04:01 PM
Greene Michelle D.Chief Information OfficerFeb 27 '26Sale228.472,746627,38712,230Mar 03 04:11 PM
Michelle GreeneofficerFeb 27 '26Proposed Sale228.472,746627,387Feb 27 04:36 PM
Alt Aaron EChief Financial OfficerFeb 18 '26Sale225.502,328524,96426,408Feb 18 04:25 PM
Aaron AltOfficerFeb 18 '26Proposed Sale225.502,328524,964Feb 18 04:16 PM
Hall Patricia HemingwayDirectorFeb 06 '26Sale229.724,000918,88028,264Feb 10 04:13 PM
Patricia Hemingway HallDirectorFeb 06 '26Proposed Sale229.694,000918,760Feb 06 04:06 PM